| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/27/2013 | CN102066924B Use of nitrated lipids for treatment of lipid disorders and obesity, and lipid- and obesity-related conditions |
| 03/27/2013 | CN102060942B 6-amino-6-deoxyinulin as well as preparation and application thereof |
| 03/27/2013 | CN102050703B Resveratrol derivate as well as preparation method and application thereof |
| 03/27/2013 | CN102046646B C-ring-substituted pregn-4-ene-21,17-carbolactone, and pharmaceutical preparations comprising the latter |
| 03/27/2013 | CN102046173B Aqueous liquid containing gatifloxacin, method for production thereof, and method for prevention of production of precipitates during storage of the aqueous liquid at low temperature or upon freezing/thawing of the aqueous liquid |
| 03/27/2013 | CN102036955B Hydroxamate-based inhibitors of deacetylases b |
| 03/27/2013 | CN102026989B Medicinal composition containing benzo[a]phenoxanthin compound as the active ingredient for preventing or treating protozoal disease |
| 03/27/2013 | CN102018691B Medicament for treating thrombotic cardiovascular and cerebrovascular diseases and application thereof |
| 03/27/2013 | CN102010366B 2,6-dichloro-5-fluoronicotinoyl fluorobenzene salicylamide compound as well as preparation and application thereof |
| 03/27/2013 | CN102000094B Ibandronic acid-containing medicinal composition and preparation process thereof |
| 03/27/2013 | CN101991624B Method for preparing total asiatic acid, asiatic acid and madecassic acid from asiatic pennywort herb and use of prepared product |
| 03/27/2013 | CN101933958B Preparation method of kiwi polyphenol microcapsules |
| 03/27/2013 | CN101932317B 稳定的药物组合物 Stable pharmaceutical compositions |
| 03/27/2013 | CN101914164B Application of polysaccharide from mulberry leaves in preventing and treating diabetes |
| 03/27/2013 | CN101912615B Cladribine formulations for improved oral and transmucosal delivery |
| 03/27/2013 | CN101912397B Flupentixol composition |
| 03/27/2013 | CN101903347B Piperidinyl and piperazinyl modulators of gamma-secretase |
| 03/27/2013 | CN101903340B Substituted N-phenyl-bipyrrolidine carboxamides and therapeutic use thereof |
| 03/27/2013 | CN101890023B Cefuroxime axetil oral liquid and preparation method thereof |
| 03/27/2013 | CN101889993B Surface-modified salbutamol suspension type non-Freon inhalation aerosol and preparation method thereof |
| 03/27/2013 | CN101854937B Novel stat3 pathway inhibitors and cancer stem cell inhibitors |
| 03/27/2013 | CN101836987B Compound niacin sustained release tablet |
| 03/27/2013 | CN101829082B Method for preparing veterinary injection of spectinomycin hydrochloride and lincomycin hydrochloride |
| 03/27/2013 | CN101809002B Morpholino pyrimidine derivatives used in diseases linked to MTOR kinase and/or PI3K |
| 03/27/2013 | CN101808651B Polymer conjugate of steroid |
| 03/27/2013 | CN101801373B Antidiabetic pharmaceutical composition |
| 03/27/2013 | CN101797241B Solid pharmaceutical compositions comprising a sip receptor agonist and a sugar alcohol |
| 03/27/2013 | CN101784259B Antifungal composition |
| 03/27/2013 | CN101781270B High-purity Febuxostat and preparation method thereof |
| 03/27/2013 | CN101768081B Inhibitor of fatty acid synthase and application thereof |
| 03/27/2013 | CN101747327B Aromatic amide thiazole derivative, preparation method and application thereof |
| 03/27/2013 | CN101744926B Chinese medicinal antibacterial lotion and preparation method thereof |
| 03/27/2013 | CN101744787B Controlled release composite containing vinpocetine |
| 03/27/2013 | CN101732469B Application of Chinese medicinal composition in preparation of medicament for treating aphonia |
| 03/27/2013 | CN101679287B Nicotinic acetylcholine receptor modulators |
| 03/27/2013 | CN101637533B Application of Chinese medicinal composition in preparation of medicament for treating virus myocarditis |
| 03/27/2013 | CN101637529B Application of Chinese medicinal composition in preparation of medicament for treating hand-foot-and-mouth disease |
| 03/27/2013 | CN101627996B Rabeprazole sodium composition and preparation method thereof |
| 03/27/2013 | CN101627028B Substituted diazepan compounds as orexin receptor antagonists |
| 03/27/2013 | CN101622257B Polymorph b of n-{2-fluoro-5-[3-(thiophene-2-carbonyl)-pyrazolo[1,5-a] pyrimidin-7-yl]-phenyl}-n-methyl-acetamide |
| 03/27/2013 | CN101616902B 2-aminooxazolines as TAAR1 ligands |
| 03/27/2013 | CN101616665B Composition useful for the treatment of type 2 diabetes |
| 03/27/2013 | CN101613352B Carbapenem derivatives containing formamide heterocyclic mercaptopyrrolidine |
| 03/27/2013 | CN101612129B Nicotinylmethylamide freeze-dried powder preparation for injection and preparation method thereof |
| 03/27/2013 | CN101605817B Cellulose derivative and method for production thereof |
| 03/27/2013 | CN101600726B Novel nucleoside analogs for treatment of viral infections |
| 03/27/2013 | CN101568639B Medium supplement for virus production |
| 03/27/2013 | CN101558040B Dihydropyridine derivatives useful as protein kinase inhibitors |
| 03/27/2013 | CN101553497B Anti-tumor compounds for inhibiting cancer growth |
| 03/27/2013 | CN101541749B Tetrahydrocyclopenta[b] indole compounds as androgen receptor modulators |
| 03/27/2013 | CN101528716B Compounds and methods for inhibiting the interaction of BCL proteins with binding partners |
| 03/27/2013 | CN101507760B Medicine composite for treating kidney disease |
| 03/27/2013 | CN101495478B Imino-imidazo-pyridine derivatives having antithrombotic activity |
| 03/27/2013 | CN101479287B Crystalline solvates and complexes of (is) -1, 5-anhydro-l-c- (3- ( (phenyl) methyl) phenyl) -d-glucitol derivatives with amino acids as sglt2 inhibitors for the treatment of diabetes |
| 03/27/2013 | CN101460482B Heterocyclic substituted pyridine compounds with cxcr3 antagonist activity |
| 03/27/2013 | CN101454311B Salt of phenoxypyridine derivative or crystal thereof and process for producing the same |
| 03/27/2013 | CN101448821B Carboxamide spirolactam cgrp receptor antagonists |
| 03/27/2013 | CN101448785B Novel dipeptidyl peptidase iv inhibitors and processes for preparation and pharmaceutical compositions thereof containing the same |
| 03/27/2013 | CN101442909B Bicycloheteroaryl compounds as P2X7 modulators and uses thereof |
| 03/27/2013 | CN101429190B 4,5-disubstitutedphenyl-3H-1,2-disulphur heterocycle pentene-3-thioketone, -ketone, -ketoxime derivants and uses thereof |
| 03/27/2013 | CN101423513B Amine pyrimidine derivates, and production method thereof, and medicament composition and use |
| 03/27/2013 | CN101407459B Monohydroxy-2-acyl phenylacetate, and preparation and use thereof |
| 03/27/2013 | CN101400697B Prevention/treatment of ichthyosis vulgaris, atopy and other disorders |
| 03/27/2013 | CN101391073B Da huoluo capsule preparation method |
| 03/27/2013 | CN101389347B Improved antitumoral treatments |
| 03/27/2013 | CN101381409B N-terminally chemically modified protein compositions and methods |
| 03/27/2013 | CN101380321B Compounds, formulations, and methods for ameliorating telangiectasias |
| 03/27/2013 | CN101370783B Salts of 1-alkylamino-1-desoxypolyols with 9-oxoacridine-10-acetic acid, medicinal preparations on base, use, preventive measures and treatment thereof |
| 03/27/2013 | CN101365801B Compositions and methods for inhibiting expression of huntingtin gene |
| 03/27/2013 | CN101355951B Novel opioid antagonists |
| 03/27/2013 | CN101355940B In vivo or in vitro method for detecting amyloid deposits having at least one amyloidogenic protein |
| 03/27/2013 | CN101346067B Glycerol levulinate ketals and use thereof |
| 03/27/2013 | CN101321748B 异喹啉衍生物 Isoquinoline derivatives |
| 03/27/2013 | CN101305018B Process and intermediates for the synthesis of caspofungin |
| 03/27/2013 | CN101296907B Diaminopyrimidines as P2X3 and P2X2/3 modulators |
| 03/27/2013 | CN101282646B Methods and products for treatment of diseases |
| 03/27/2013 | CN101277950B Inhibitors of serine proteases |
| 03/27/2013 | CN101252920B Stable fixed-dose unitary formulations containing tenofovir, a surfactant, efavirenz and emtricitabine |
| 03/27/2013 | CN101247799B Inhibitors of fibroblast activation protein alpha |
| 03/27/2013 | CN101243056B Crystal of phenylalanine derivative, process for producing the same and use thereof |
| 03/27/2013 | CN101223269B Compositions and methods for treating tissue |
| 03/27/2013 | CN101223175B Diazabenzo[de]anthracen-3-one compounds and methods for inhibiting PARP |
| 03/27/2013 | CN101195615B Salt of imidazole-carboxylic acid derivant, production method and pharmaceutical composition thereof |
| 03/27/2013 | CN101189016B Device and methods for treating paranasal sinus conditions |
| 03/27/2013 | CN101188996B Surface-modified microparticles and methods of forming and using the same |
| 03/27/2013 | CN101185611B Technique for preparing silybin fine particles by using supercritical fluid crystallization technology |
| 03/27/2013 | CN101180264B Benzoic acid ester compounds, compositions, uses and methods related thereto |
| 03/27/2013 | CN101171018B Compositions and methods for topical application and transdermal delivery of botulinum toxins |
| 03/27/2013 | CN101155804B Piperazine-substituted benzothiophenes for treatment of mental disorders |
| 03/27/2013 | CN101137623B N-sulphonylpyrroles and use thereof as histone deacetylase inhibitors |
| 03/27/2013 | CN101128427B Heterocyclic compounds as ccr2b antagonists |
| 03/27/2013 | CN101111154B Combination of immuno gene therapy and chemotherapy for treatment of cancer and hyperproliferative diseases |
| 03/27/2013 | CN101083981B Flavonoid composition for treating oral diseases |
| 03/27/2013 | CN101037409B Process for the preparation of n-substituted 2-cyanopyrrolidines |
| 03/27/2013 | CN101027279B Synthesis of tetracyclines and analogues thereof |
| 03/27/2013 | CN101023090B Prodrugs of HIV protease inhibitors |
| 03/26/2013 | US8404874 (20R,25S)-2-Methylene-19,26-Dinor-1α,25-Dihydroxyvitamin D3 in crystalline form |
| 03/26/2013 | US8404869 Phenanthrenequinone-based compound and pharmaceutical composition containing the same for the treatment or prevention of disease involving metabolic syndrome |
| 03/26/2013 | US8404866 Substituted heterocyclic mercaptosulfonamide metalloprotease inhibitors |
| 03/26/2013 | US8404859 Thiazole and thiophene compounds |